iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients

World-leading surgeons to join iSTAR Medical's STAR-V study WAVRE, Belgium, July 15, 2021 -- (Healthcare Sales & Marketing Network) -- iSTAR Medical, a med-tech company developing minimally-invasive implants for glaucoma surgery (MIGS), announced today... Devices, Ophthalmology, FDA iSTAR Medical, micro-invasive glaucoma surgery, MINIject , glaucoma

https://salesandmarketingnetwork.com/news_release_bs.html?ID=2047019

Source: HSMN NewsFeed - July 15, 2021 Category: Pharmaceuticals Source Type: news